BRAFV600E accelerates disease progression and enhances immune suppression in a mouse model of B-cell leukemiaYo-Ting Tsai(Comprehensive Blood & Cancer Center), David Lucas(Comprehensive Blood & Cancer Center)Blood AdvancesOctober 30, 201710.1182/bloodadvances.2017006593Cited by 5SaveCiteExport RISWatch citationsRelated PapersMcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximab|Blood|2008|69